Wednesday, October 25, 2017

Information from the ADA and MD Anderson Cancer Center's Symposium on Oropharyngeal Cancer

MD Anderson Cancer Center Logo.jpgADA Logo.png
I’m going to be focus on oral cancer a lot in the foreseeable future.  First because I’m very passionate about helping prevent it or detect it early and second because there is a lot of information that has suddenly become available.  Last week at the ADA Meeting in Atlanta, the MD Anderson Cancer Center and the ADA had a joint symposium dealing with this terrible disease.  Here is just a little of the information from that meeting:
Erich Sturges, M.D., a head and neck surgeon at MD Anderson, focused his discussion on the importance of ensuring boys receive the HPV vaccine, which can prevent the infections that can lead to cancer.  According to the CDC, HPV is thought to cause 70% of oropharyngeal cancers in the U.S.  He also stated oropharyngeal cancer is “nine times more common in men than women.”
Dr. Melinda Wharton, acting director at the National Vaccine Program Office within the U.S. Department of Health and Human Services, also presented and discussed the HPV vaccine, highlighting that only about 60 percent of adolescent boys and girls nationally have received one of more doses of the vaccine.  The CDC recommends children receive two doses of the HPV vaccine at ages 11-12.

No comments:

Post a Comment